BACKGROUND: Viral-induced asthma exacerbations, which exhibit both Th1-type neutrophilia and Th2-type inflammation, associate with secretion of Interleukin (IL)-1beta. IL-1beta induces neutrophilic inflammation. It may also increase Th2-type cytokine expression. We hypothesised that IL-1beta is causally involved in both Th1 and Th2 features of asthma exacerbations. This hypothesis is tested in our mouse model of viral stimulus-induced asthma exacerbation. METHOD: Wild-type (WT) and IL-1beta deficient (IL-1beta(-/-)) mice received house dust mite (HDM) or saline intranasally during three weeks followed by intranasal dsRNA (PolyI:C molecule known for its rhinovirus infection mimic) for three consecutive days to provoke exacerbation. Bronchoalveolar lavage fluid was analysed for inflammatory cells and total protein. Lung tissues were stained for neutrophilic inflammation and IL-33. Tissue homogenates were analysed for mRNA expression of Muc5ac, CXCL1/KC, TNF-alpha, CCL5, IL-25, TSLP, IL-33, IL-1beta, CCL11 and CCL2 using RT-qPCR. RESULTS: Expression of IL-1beta, neutrophil chemoattractants, CXCL1 and CCL5, the Th2-upstream cytokine IL-33, and Muc5ac were induced at exacerbation in WT mice and were significantly inhibited in IL-1beta(-/-) mice at exacerbation. Effects of HDM alone were not reduced in IL-1beta-deficient mice. CONCLUSION: Without being involved in the baseline HDM-induced allergic asthma, IL-1beta signalling was required to induce neutrophil chemotactic factors, IL-33, and Muc5ac expression at viral stimulus-induced exacerbation. We suggest that IL-1beta has a role both in neutrophilic and Th2 inflammation at viral-induced asthma exacerbations.